HD Lifesciences completes testing for its NanoHive™ Cervical Interbody
BOSTON (PRWEB) January 15, 2018 -- HD Lifesciences has announced the completion of mechanical testing for its forthcoming family of cervical interbodies. Co-Founder and Chief Product Officer Ian Helmar described the significance of the benchmark: “Passing cervical testing is more evidence of the durability of our Soft Titanium™ lattice since the cervical testing battery includes test modes not required in lumbar. We actually found that our lattice is effectively stronger in torsion than compression. The 3d-printed products on the market have major differences between them and we are excited to further demonstrate the distinct advantages of our technology.”
HD Lifesciences cervical interbodies are not yet approved for use in the US or Europe. For more information on Soft Titanium™, NanoHive™ lumbar interbody availability, or new product launches, please email info(at)HDlifesciences(dot)com or visit http://www.hdlifesciences.com
Alex Rossi, HD Lifesciences, http://www.hdlifesciences.com, +1 (978) 778-8874, [email protected]
Share this article